Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes Labialis

NCT00230867 is registered in ClinicalTrials.gov with Transport Pharmaceuticals as lead sponsor.

NCT NCT00230867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00230867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes Labialis
Lead sponsor
Transport Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
December 31, 2005
Enrollment
1,800
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

herpes labialis